Compliant Analysis of Patient Samples and Data

Part of paid clinical trials in Los Angeles, California.

Sponsor
Sequenom, Inc.
Study ID
NCT04364503
Status
Enrolling By Invitation

Conditions

  • Cancer
  • Infectious Disease
  • Pregnancy Related

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Accepted

Interventions

  • Multiple interventions depending on diagnostic test being run. — DEVICE
    Remnant samples and corresponding data from multiple diagnostic tests will be stored for future research and development.

Study Details

Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.

Key Dates

First listed
Apr 28, 2020
Start date
Mar 17, 2018
Status verified
Jul 2026
Primary completion
Mar 17, 2030
Completion
Aug 15, 2030

Study Design

Enrollment
2,000 participants (estimated)

Primary Outcome Measure

Remnant samples and data for research and development [ Time Frame: Retrospective and Prospective collection. Samples and data may be collected for up 12 months after enrollment. ]

Locations (9)

FacilityCityStateZIPSite coordinators
LabcorpLos AngelesCalifornia90064-
Sequenom, IncSan DiegoCalifornia92121-
Labcorp - Monogram BiosciencesSouth San FranciscoCalifornia94080-
Labcorp - EsoterixEnglewoodColorado80112-
Labcorp - LitholinkItascaIllinois60143-
Labcorp - OmniseqBuffaloNew York14203-
LabcorpBurlingtonNorth Carolina27215-
LabcorpResearch Triangle ParkNorth Carolina27709-
Labcorp - CytogeneticsResearch Triangle ParkNorth Carolina27709-

Find similar trials in Los Angeles, CA

By research site
Labcorp· Los Angeles, CASequenom, Inc· San Diego, CALabcorp - Monogram Biosciences· South San Francisco, CALabcorp - Esoterix· Englewood, COLabcorp - Litholink· Itasca, ILLabcorp - Omniseq· Buffalo, NY

Related Studies